Clinical Trials

If you would like to explore the possibility of participating in a clinical trial at Guthrie, please call 1-800-836-0388.
Title: CeD-LA-3001: A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide for Relief of Persistent Symptoms in Patients with Celiac Disease on a Gluten Free Diet
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Michael J Georgetson, MD
Sponsors: Innovate
Details (Indentifier #): NCT03569007
Title: CHS1221: A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository Formulation Administered with the Sephure® Suppository Applicator in Subjects with Ulcerative Colitis of the Rectum
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Michael J Georgetson, MD
Sponsors: Cristcot
Details (Indentifier #): NCT04469686
Title: Cultivate-APD334-202: A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Michael J Georgetson, MD
Sponsors: Arena
Details (Indentifier #): NCT04173273
Title: Limited access protocol for the use of oral cisapride in the treatment of refractory gastroesophageal reflux disease and other gastrointestinal motility disorders. CIS-USA-154
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Thomas J McDonald, MD
Sponsors: Janssen
Details (Indentifier #): none
Title: M14-533, A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Michael J Georgetson, MD
Sponsors: AbbVie
Details (Indentifier #): NCT03006068
Title: M20-259: A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease Who Have Failed Anti-TNF therapy
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Michael J Georgetson, MD
Sponsors: AbbVie
Details (Indentifier #): NCT04524611
Title: SERES-013: ECOSPOR IV: AN OPEN-LABEL EXTENSION OF STUDY SERES-012 AND OPEN-LABEL PROGRAM FOR EVALUATING SER-109 IN ADULT SUBJECTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (RCDI)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Michael J Georgetson, MD
Sponsors: Seres
Details (Indentifier #): NCT03183141